Royalty Pharma plc (RPRX) Reports Q4 results
Tweet
Share
E-mail
Get Alerts RPRX Hot Sheet
Price: $61.73 --0%
Financial Fact:
General and administrative: 997K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
General and administrative: 997K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Royalty Pharma plc (NASDAQ: RPRX) reported Q4 Revenue for the quarter at $622 million versus the consensus estimate of $796.14 million.
For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
- Navios Maritime Partners (NMM) Tops Q2 EPS by 34c
- Evaxion posts $3.7M Q2 loss, advances cancer vaccine pipeline
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
